ES525219A0 - Procedimiento para preparar nuevos derivados acilhidroxilaminicos de acidos grasos insaturados. - Google Patents

Procedimiento para preparar nuevos derivados acilhidroxilaminicos de acidos grasos insaturados.

Info

Publication number
ES525219A0
ES525219A0 ES525219A ES525219A ES525219A0 ES 525219 A0 ES525219 A0 ES 525219A0 ES 525219 A ES525219 A ES 525219A ES 525219 A ES525219 A ES 525219A ES 525219 A0 ES525219 A0 ES 525219A0
Authority
ES
Spain
Prior art keywords
fatty acids
unsaturated fatty
derivatives
acilhidroxilaminic
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES525219A
Other languages
English (en)
Other versions
ES8603807A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES525219A0 publication Critical patent/ES525219A0/es
Publication of ES8603807A1 publication Critical patent/ES8603807A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/09Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
    • C07C29/10Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/04Acyclic alcohols with carbon-to-carbon triple bonds
    • C07C33/048Acyclic alcohols with carbon-to-carbon triple bonds with double and triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/24Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/18Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon triple bonds as unsaturation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES525219A 1982-08-30 1983-08-29 Procedimiento para preparar nuevos derivados acilhidroxilaminicos de acidos grasos insaturados. Expired ES8603807A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/412,477 US4497827A (en) 1982-08-30 1982-08-30 Arachidonic acid analogues as anti-inflammatory and anti-allergic agents

Publications (2)

Publication Number Publication Date
ES525219A0 true ES525219A0 (es) 1986-01-16
ES8603807A1 ES8603807A1 (es) 1986-01-16

Family

ID=23633154

Family Applications (4)

Application Number Title Priority Date Filing Date
ES525219A Expired ES8603807A1 (es) 1982-08-30 1983-08-29 Procedimiento para preparar nuevos derivados acilhidroxilaminicos de acidos grasos insaturados.
ES540853A Expired ES8606235A1 (es) 1982-08-30 1985-03-01 Procedimiento para preparar nuevos derivados hidroximetilce-tonicos de acidos grasos insaturados
ES540855A Expired ES8607955A1 (es) 1982-08-30 1985-03-01 Procedimiento para preparar nuevos derivados tetrazolicos deacidos grasos insaturados
ES540854A Expired ES8704878A1 (es) 1982-08-30 1985-03-01 Procedimiento para preparar nuevos derivados amidicos de acidos grasos insaturados

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES540853A Expired ES8606235A1 (es) 1982-08-30 1985-03-01 Procedimiento para preparar nuevos derivados hidroximetilce-tonicos de acidos grasos insaturados
ES540855A Expired ES8607955A1 (es) 1982-08-30 1985-03-01 Procedimiento para preparar nuevos derivados tetrazolicos deacidos grasos insaturados
ES540854A Expired ES8704878A1 (es) 1982-08-30 1985-03-01 Procedimiento para preparar nuevos derivados amidicos de acidos grasos insaturados

Country Status (15)

Country Link
US (1) US4497827A (es)
EP (1) EP0104468B1 (es)
JP (1) JPS5965036A (es)
KR (1) KR840005722A (es)
AT (1) ATE20885T1 (es)
AU (1) AU1852083A (es)
CA (1) CA1209578A (es)
DE (1) DE3364718D1 (es)
DK (1) DK393583A (es)
ES (4) ES8603807A1 (es)
FI (1) FI833062A (es)
IE (1) IE55902B1 (es)
NO (1) NO833092L (es)
NZ (1) NZ205403A (es)
ZA (1) ZA836395B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates
DE3518655A1 (de) * 1985-05-24 1986-11-27 Grünenthal GmbH, 5190 Stolberg Neue phenolderivate, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel
FR2584400B1 (fr) * 1985-07-05 1988-02-19 Cird Esters et amides de l'acide eicosatriynoique et leur application en pharmacie et en cosmetique
DE3604050A1 (de) * 1986-02-08 1987-08-13 Boehringer Mannheim Gmbh Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4761403A (en) * 1986-04-09 1988-08-02 Abbott Laboratories Lipoxygenase inhibiting compounds
US4707494A (en) * 1986-08-26 1987-11-17 E. R. Squibb & Sons, Inc. 7-oxabicyclo(2.2.1)heptane compounds useful in the treatment of inflammation
US4672075A (en) * 1986-08-26 1987-06-09 E. R. Squibb & Sons 7-Oxabicyclo(2.2.1)heptane hydroxamic acid derivatives useful as antiinflammatory, antiasthma and antipsoriatic agents
US4908384A (en) * 1986-08-29 1990-03-13 Mcneilab, Inc. Fatty acid leukotriene synthesis inhibitors
FR2609026B1 (fr) * 1986-12-31 1989-03-31 Cird Amides de l'acide eicosatetraynoique et leur application en pharmacie et en cosmetique
US5145861A (en) * 1987-11-04 1992-09-08 Merrell Dow Pharmaceuticals Inc. Fluorinated arachidonic acid derivatives
US4963541A (en) * 1989-02-22 1990-10-16 Abbott Laboratories Pyrimido-pyrimidine lipoxygenase inhibiting compounds
ATE101114T1 (de) * 1989-05-02 1994-02-15 Merrell Dow Pharma Flourierte abkoemmlinge von archidsaeuren.
US5225429A (en) * 1989-05-02 1993-07-06 Merrell Dow Pharmaceuticals Inc. Fluorinated arachidonic acid derivatives
DE69910373T2 (de) * 1998-05-04 2004-04-01 The University Of Connecticut, Farmington Analgetische und immunomodulierende cannabinoiden
US7897598B2 (en) * 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
IL125731A (en) 1998-08-11 2004-06-20 Zvi Yehuda Acylates which are products of neurotransmitters and essential fatty acids, pharmaceutical compositions containing them, use of such acylates in the manufacture of medicaments, and method for treating nervous diseases in non-human animals
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
US6900236B1 (en) * 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
AU778159B2 (en) 1999-10-18 2004-11-18 University Of Connecticut, The Peripheral cannabinoid receptor (CB2) selective ligands
US6943266B1 (en) 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
EP1361876A4 (en) * 2001-01-26 2004-03-31 Univ Connecticut NEW CANNABIMIMETIC LIGANDS
EP1363632B1 (en) 2001-01-29 2010-08-25 The University of Connecticut Receptor selective cannabimimetic aminoalkylindoles
US7057076B2 (en) * 2001-07-13 2006-06-06 University Of Connecticut Bicyclic and tricyclic cannabinoids
JP2005510492A (ja) * 2001-10-26 2005-04-21 ユニバーシティ オブ コネチカット 新規な種類の効力のあるカンナビミメティックリガンド
AU2003265663A1 (en) 2002-08-23 2004-03-11 University Of Connecticut Keto cannabinoids with therapeutic indications

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE319677B (es) * 1965-03-27 1970-01-19 Sumitomo Chemical Co
GB1074693A (en) * 1966-01-03 1967-07-05 Sumitomo Chemical Co Purification of fatty acid amide derivatives
US3427316A (en) * 1966-05-02 1969-02-11 Millmaster Onyx Corp Quaternary ammonium hydroxamates
US3995059A (en) * 1966-10-04 1976-11-30 Sumitomo Chemical Company, Limited Pharmaceutical compositions containing fatty acid amide derivatives
FR2140369A1 (en) * 1971-06-11 1973-01-19 Ceskoslovenska Akademie Ved Ethanol palmitamide - for treatment of upper respiratory infections and for detoxication
BE788209A (fr) * 1971-09-01 1973-02-28 Pfizer Derives tetrazoyliques des prostaglandines naturelles
NL7208324A (en) * 1972-06-19 1973-12-21 Animal feed supplement - consisting of long chain acylhydroxyamide
DE2256347C3 (de) * 1972-11-17 1982-01-07 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von α,β -ungestättigten Ketonen
DE2343055A1 (de) * 1973-08-25 1975-03-06 Basf Ag Ungesaettigte nitrile
FR2264522A1 (en) * 1974-03-22 1975-10-17 Rouchy Maurice Vitamin F cpds having surface active properties - comprise linoleic, linolenic and arachidonic acid radical joined via O or N to polyalcohols
JPS601283B2 (ja) * 1976-06-08 1985-01-14 帝人株式会社 包接化合物並びにその製造法
NL7614113A (nl) * 1976-12-18 1978-06-20 Akzo Nv Hydroxamzuren.
US4336372A (en) * 1979-04-02 1982-06-22 The Upjohn Company 2-Decarboxy-2-tetrazolyl-PG2 compounds
US4277410A (en) * 1980-05-02 1981-07-07 Emery Industries, Inc. Process for the production of carboxylic amides using alkyltin catalysts

Also Published As

Publication number Publication date
KR840005722A (ko) 1984-11-16
CA1209578A (en) 1986-08-12
DK393583A (da) 1984-03-01
ES540854A0 (es) 1987-05-01
ES8607955A1 (es) 1986-06-16
ES8606235A1 (es) 1986-04-16
EP0104468B1 (en) 1986-07-23
US4497827A (en) 1985-02-05
ZA836395B (en) 1985-04-24
DE3364718D1 (en) 1986-08-28
IE832016L (en) 1984-02-29
ES540855A0 (es) 1986-06-16
DK393583D0 (da) 1983-08-29
ES8704878A1 (es) 1987-05-01
FI833062A0 (fi) 1983-08-29
FI833062A (fi) 1984-03-01
IE55902B1 (en) 1991-02-14
ATE20885T1 (de) 1986-08-15
AU1852083A (en) 1984-03-08
NO833092L (no) 1984-03-01
ES8603807A1 (es) 1986-01-16
JPS5965036A (ja) 1984-04-13
EP0104468A1 (en) 1984-04-04
ES540853A0 (es) 1986-04-16
NZ205403A (en) 1986-10-08

Similar Documents

Publication Publication Date Title
ES525219A0 (es) Procedimiento para preparar nuevos derivados acilhidroxilaminicos de acidos grasos insaturados.
DE3585981D1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.
ATA242288A (de) Dosierungsform für die behandlung kardiovaskulärer erkrankungen
ATE251158T1 (de) Indolizin spal2 inhibitoren
DE69728594T2 (de) Chromfreie Zusammensetzung für die Behandlung von metallischen Oberflächen
PT915842E (pt) Esteres nitratos e sua utilizacao para condicoes neurologicas
DE3873855D1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
ATA585676A (de) Chirurgisch wirksamer, antiseptischer biologischer verband und verfahren zur seiner herstellung
ATE284217T1 (de) Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen
DE3877521D1 (de) Vorrichtung fuer die behandlung von abwasser aus photoprozessen.
DE59801385D1 (de) Durchlaufanlage für die behandlung von werkstücken
PT87642A (pt) Process for the preparation of dopamine-beta-hydroxylase inhibitors
IL55385A0 (en) Process for the manufacture of fatty acid nitriles and glycerides,especially from natural fats and oils
LU81429A1 (de) Mittel zur behandlung seborrhoischer zustaende
DE69302799D1 (de) Zusammensetzung für die Behandlung von Kesselwasser
DE3866653D1 (de) Zusammensetzung fuer die behandlung der epidermis.
IT8067668A0 (it) Procedimento per il trattamento preventivo nella fabbricazione di acciaio non stagnato
IE811612L (en) Thiazoles
ATE5372T1 (de) Zusammensetzungen fuer die behandlung von krankheiten der kreislauforgane.
RO86562A2 (ro) Compozitie vegetala medicamentoasa pentru tratarea unor afectiuni hepato-biliare
ES512448A0 (es) Procedimiento para el tratamiento de una escoria fosfurada.
ATE75617T1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.
IL49756A0 (en) Continuous process for the enzymatic treatment of plant or animal tissues
ATE79541T1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
ES2062317T3 (es) Procedimiento e intermedios para la preparacion de 3s-amino-2r-hidroxi-alcanoatos de isopropilo.